Demos highlight maturity and capability of Raytheon NGSRI solution TUCSON, Ariz. , Feb. 18, 2025 /PRNewswire/ -- Raytheon, an RTX (NYSE: RTX) business, announced a series of 10 successful subsystem demonstrations for the U.S. Army's Next-Generation Short-Range Interceptor (NGSRI), which will eventually replace the Stinger® surface-to-air missile.

image for news RTX's Raytheon completes 10 subsystem demonstrations for U.S. Army's Next-Generation Short-Range Interceptor program

Onfolio Holdings Inc. Releases Shareholder Letter — Neutral

ONFO   GlobeNewsWire — February 18, 2025

WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) (the "Company" or "Onfolio"), a company that acquires and manages a diversified portfolio of online businesses, today announced that its chairman and chief executive officer released the following letter to Onfolio shareholders.

image for news Onfolio Holdings Inc. Releases Shareholder Letter

Travelzoo Q4 2024 Earnings Conference Call on February 25 at 11:00 AM ET — Neutral

TZOO   PRNewsWire — February 18, 2025

NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO): WHAT: Travelzoo, the club for travel enthusiasts, will host a conference call to discuss the Company's financial results for the fourth quarter ended December 31, 2024. Travelzoo will issue a press release reporting its results before the market opens on February 25, 2025.

image for news Travelzoo Q4 2024 Earnings Conference Call on February 25 at 11:00 AM ET

BROOMFIELD, Colo., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Noodles & Company (NASDAQ: NDLS) today announced that it will host a conference call to discuss its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025 at 4:30 p.m. ET. Drew Madsen, Chief Executive Officer, and Mike Hynes, Chief Financial Officer, will host the call. A press release with fourth quarter and full year 2024 financial results will be issued after the market close that same day.

image for news Noodles & Company to Announce Fourth Quarter and Full Year 2024 Results on March 6, 2025

Bears Suddenly at Risk as S&P 500 Support Steps Up — Positive

IVV  SPLG  SPXL  SPY  SSO  UPRO  VOO   Schaeffers Research — February 18, 2025

Last week, investors absorbed more headlines on tariffs, plus Fed Chairman Jerome Powell's testimony to Congress, inflation data, and the release of the January consumer price index (CPI) and producer price index (PPI) reports.

image for news Bears Suddenly at Risk as S&P 500 Support Steps Up

The integration allows Rapsodo MLM2PRO™users to refine their game with accurate club distance measuring and offers fun activities such as skills challenges The integration allows Rapsodo MLM2PRO™users to refine their game with accurate club distance measuring and offers fun activities such as skills challenges

image for news Rapsodo Partners with TruGolf's E6 APEX to Enhance Simulated Golf, Adding Improved Player Analysis and Practice Capabilities

Medtronic (MDT) Tops Q3 Earnings Estimates — Positive

MDT   Zacks Investment Research — February 18, 2025

Medtronic (MDT) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.30 per share a year ago.

image for news Medtronic (MDT) Tops Q3 Earnings Estimates

U.S. utility Constellation Energy beat Wall Street estimates for fourth-quarter profit on Tuesday, benefiting from lower expenses and rising demand for power.

image for news Constellation Energy beats profit estimates on data center-driven power demand

Watsco: Q4 Earnings Beat Expectations — Positive

WSO   The Motley Fool — February 18, 2025

HVAC/R equipment distributor specialist Watsco (WSO 1.51%) reported robust fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 18, that topped analysts' consensus estimates. Key highlights included earnings per share (EPS) of $2.37, rising from $2.06 the previous year and outperforming the $2.19 estimate.

image for news Watsco: Q4 Earnings Beat Expectations

CARMEL, Ind. , Feb. 18, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today positive preliminary results from the clinical research study being conducted by Indiana University (IU) of its flagship mental health product, Syrenity.

image for news Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University

Separately, Company leaders will attend and present at J.P. Morgan's 2025 Leveraged Finance Conference on February 24, 2025 Separately, Company leaders will attend and present at J.P. Morgan's 2025 Leveraged Finance Conference on February 24, 2025

image for news Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

SAN FRANCISCO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- On Jan. 29, 2025, the price of software solutions company Manhattan Associates, Inc. (NASDAQ: MANH) tumbled $72.26 lower (-24%) after reporting its Q4 and FY 2024 financial results and providing 2025 revenue guidance which was below analysts' consensus estimates. Hagens Berman urges Manhattan Associates investors who suffered substantial losses to submit your losses now.

image for news Manhattan Associates (MANH) Shares Tumble 24% After Citing Headwinds for Services Business & Revealing 2025 GAAP EPS Expected to Shrink – Hagens Berman

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

image for news Spot gold spikes above $2,918/oz after New York manufacturing index rises to 5.70 in February

Small-Caps Could Be Ideal Tariff Refuge — Positive

OUSM   ETF Trends — February 18, 2025

Equities are enduring a turbulent spell at the hands of President Trump's tariff talk. Yes, the White House has backed off of trade levies against Canada, Colombia, and Mexico, for now at least.

image for news Small-Caps Could Be Ideal Tariff Refuge

QGRW Unites Growth & Quality — Positive

QGRW   ETF Trends — February 18, 2025

Despite the talk about growth stocks encountering headwinds, the Nasdaq 100 and S&P 500 Growth indexes are higher over the past month. They're also both higher since the start of the year.

image for news QGRW Unites Growth & Quality

Don't Overlook Midcap Firms in Enhanced Midcap ETF FMDE — Positive

FMDE   ETF Trends — February 18, 2025

If investors entered 2025 excited by the prospect of rising small caps, they may first want to consider midcaps. Midcap firms offer much of the same upside that small caps do, with some additional benefits from their larger size.

image for news Don't Overlook Midcap Firms in Enhanced Midcap ETF FMDE

3 Options to Capitalize on Cloud & AI Growth — Positive

CLDL  MSFU  UBOT   ETF Trends — February 18, 2025

We'll most likely see growth continue in the near and long term for cloud computing as well as artificial intelligence (AI). This gives traders a pair of options to capitalize on: the Direxion Daily Cloud Computing Bull 2X Shares ETF (CLDL) and the Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X ETF (UBOT).

image for news 3 Options to Capitalize on Cloud & AI Growth

TVAL Combines Diversification & Outperformance YTD — Positive

IWD  TVAL   ETF Trends — February 18, 2025

Advisors and investors seeking to diversify their equity portfolios this year should consider the T. Rowe Price Value ETF (TVAL).

image for news TVAL Combines Diversification & Outperformance YTD

Wix Gears Up to Report Q4 Earnings: Here's What You Should Know — Positive

WIX   Zacks Investment Research — February 18, 2025

WIX's Q4 performance is likely to have gained from a robust product portfolio amid macro uncertainty and foreign currency fluctuations.

image for news Wix Gears Up to Report Q4 Earnings: Here's What You Should Know

Should You Hold IDEXX Stock in Your Portfolio for Now? — Positive

IDXX   Zacks Investment Research — February 18, 2025

IDEXX's robust strength in the CAG Diagnostics business and strong global performance are highly promising.

image for news Should You Hold IDEXX Stock in Your Portfolio for Now?